Drugs + Money
Cannabis Consumers Have Power: Meet Some Pioneers of Industry Inclusivity
In the hyper-commodifying cannabis industry, Mary Pryor of New York City is raising her ...
Hep C Treatment Is Scarce Behind Bars—And Jeopardized Upon Release
In April 2010, Sean tested positive for the hepatitis C virus (HCV) in Seattle’s ...
Indivior Case: Don’t Throw Out the Buprenorphine With the Bathwater
In the lucrative but hit-and-miss opioid use disorder treatment field, buprenorphine is one medication ...
The Justice Gap: Trump Budget Attack on Legal Aid Orgs Targets Drug Users, HIV-Positive People
Many of the policies peddled by the Trump administration sound like a broken record. ...
US Buprenorphine Prices: A Complete List
To accompany Alison Knopf’s April 16 article about buprenorphine in light of federal charges ...
#BreakThePatent: Activists Fight for Universal Access to Overpriced HIV Medication
Nothing for us without us!” In a spacious ballroom crowded with attendees at the ...
Exclusive: What Happened to the Funding for LA’s Cannabis Social Equity Program?
It was mid-morning on March 15 when around 25 activists and city officials gathered ...
“Nation’s Most Comprehensive Lawsuit”—Now NY Takes On Purdue and the Sacklers
Museums around the world, from New York City’s Guggenheim to London’s Tate Modern, have ...
Rethinking Ketamine in Light of a Newly Approved Depression Treatment
On March 5, the US Food and Drug Administration (FDA) approved the prescription treatment ...
Guess Which Country Pays the Most for Illicit Drugs?
The latest Bloomberg Global Vice Index, an annual price tracker of illicit drugs, reveals ...
